Komori
Wakou Shokuhin (2813) · FactFull-year amount updated

Recognition of R&D Activity Expenses

First written in FY2017-Q1. . Latest entry: FY2026.

32entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2017-Q1 – FY20262016: 220162017: 420172018: 420182019: 420192020: 320202021: 420212022: 420222023: 420232024: 120242025: 120252026: 12026
Same theme, other companies
Recognition and Disclosure of R&D ExpensesA theme 83 companies write about · 0 as a headwind · 20 as a tailwind

58 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 83 companies compared. The sentences above are computed from all 83.
Full recordFilings, disclosures and news, newest first
  1. FY2026Full-year amount updatedAnnual report

    「R&D expenses incurred during the consolidated fiscal year were ¥276.721 million for the Japan segment and ¥0.765 million for the U.S. segment.」

    Annual R&D expenses were ¥276.721 million in Japan and ¥0.765 million in the U.S., for a total of ¥277.486 million.
  2. FY2026-H1Interim amount updatedAnnual report

    「Total research and development expenses amounted to ¥141 million in the current interim consolidated accounting period. By segment, research and development expenses amounted to ¥141 million in the Japan segment and ¥0 million in the United States segment.」

    R&D expenses for the interim consolidated accounting period were ¥141 million, comprising ¥141 million for the Japan segment and ¥0 million for the U.S. segment.
  3. FY2024-Q3Quarterly cumulative amount updatedAnnual report

    「Total research and development expenses amounted to ¥138 million in the current third-quarter cumulative period. By segment, research and development expenses amounted to ¥138 million in the Japan segment and ¥0 million in the United States segment.」

    Research and development expenses for the third-quarter cumulative period amounted to ¥138 million, comprising ¥138 million in the Japan segment and ¥0 million in the United States segment.
  4. FY2024-Q2Cumulative amount updatedAnnual report

    「Total research and development expenses amounted to ¥103 million in the current second-quarter cumulative period. By segment, research and development expenses amounted to ¥103 million in the Japan segment and ¥0 million in the United States segment.」

    Research and development expenses for the second-quarter cumulative period amounted to ¥103 million, comprising ¥103 million in the Japan segment and ¥0 million in the United States segment.
  5. FY2024-Q1Quarterly cumulative amount updatedAnnual report

    「Total research and development expenses amounted to ¥48 million in the current first-quarter cumulative period. By segment, research and development expenses amounted to ¥48 million in the Japan segment and ¥0 million in the United States segment.」

    Research and development expenses for the first-quarter cumulative period amounted to ¥48 million, comprising ¥48 million in the Japan segment and ¥0 million in the United States segment.
  6. FY2023Full-year amount updatedAnnual report

    「Research and development expenses incurred during the current consolidated fiscal year amounted to ¥204.834 million in the Japan segment and ¥309 thousand in the United States segment.」

    Annual research and development expenses amounted to ¥204.834 million in Japan and ¥309 thousand in the United States, for a total of ¥205.144 million.
  7. FY2023-Q3Cumulative amount updatedAnnual report

    「Total research and development expenses amounted to ¥149 million in the current third-quarter cumulative period. By segment, research and development expenses amounted to ¥149 million in the Japan segment and ¥0 million in the United States segment.」

    Research and development expenses for the third-quarter cumulative period amounted to ¥149 million, comprising ¥149 million in the Japan segment and ¥0 million in the United States segment.
  8. FY2023-Q2Cumulative amount updatedAnnual report

    「Total research and development expenses amounted to ¥99 million in the current second-quarter cumulative period. By segment, research and development expenses amounted to ¥99 million in the Japan segment and ¥0 million in the United States segment.」

    Research and development expenses for the second-quarter cumulative period amounted to ¥99 million, comprising ¥99 million in the Japan segment and ¥0 million in the United States segment.
  9. FY2023-Q1Quarterly cumulative amount updatedAnnual report

    「Total research and development expenses amounted to ¥53 million in the current first-quarter cumulative period. By segment, research and development expenses amounted to ¥53 million in the Japan segment and ¥0 million in the United States segment.」

    Research and development expenses for the first-quarter cumulative period amounted to ¥53 million, comprising ¥53 million in the Japan segment and ¥0 million in the United States segment.
  10. FY2022Full-year amount updatedAnnual report

    「Research and development expenses incurred during the current consolidated fiscal year amounted to ¥226.122 million in the Japan segment and ¥248 thousand in the United States segment.」

    Annual research and development expenses amounted to ¥226.122 million in Japan and ¥248 thousand in the United States, for a total of ¥226.370 million.
  11. FY2022-Q3Cumulative amount updatedAnnual report

    「Total research and development expenses amounted to ¥271 million in the current third-quarter cumulative period. By segment, research and development expenses amounted to ¥271 million in the Japan segment and ¥0 million in the United States segment.」

    Research and development expenses for the third-quarter cumulative period amounted to ¥271 million, comprising ¥271 million in the Japan segment and ¥0 million in the United States segment. There has been no material change in research and development activities.
  12. FY2022-Q2Cumulative amount updatedAnnual report

    「Total research and development expenses amounted to ¥127 million in the current second-quarter cumulative period. By segment, research and development expenses amounted to ¥127 million in the Japan segment and ¥0 million in the United States segment.」

    Research and development expenses for the second-quarter cumulative period amounted to ¥127 million, comprising ¥127 million in the Japan segment and ¥0 million in the United States segment.
  13. FY2022-Q1Quarterly cumulative amount updatedAnnual report

    「Total research and development expenses amounted to ¥59 million in the current first-quarter cumulative period. By segment, research and development expenses amounted to ¥59 million in the Japan segment and ¥0 million in the United States segment.」

    Research and development expenses for the first-quarter cumulative period amounted to ¥59 million, comprising ¥59 million in the Japan segment and ¥0 million in the United States segment.
  14. FY2021Full-year amount updatedAnnual report

    「Research and development expenses incurred during the current consolidated fiscal year amounted to ¥215.017 million in the Japan segment and ¥279 thousand in the United States segment.」

    Annual research and development expenses amounted to ¥215.017 million in Japan and ¥279 thousand in the United States, for a total of ¥215.296 million.
  15. FY2021-Q3Quarterly cumulative amount updatedAnnual report

    「Total research and development expenses amounted to ¥190 million in the current third-quarter cumulative period. By segment, research and development expenses amounted to ¥190 million in the Japan segment and ¥0 million in the United States segment.」

    Research and development expenses for the third-quarter cumulative period amounted to ¥190 million, comprising ¥190 million in the Japan segment and ¥0 million in the United States segment.
  16. FY2021-Q2Quarterly cumulative amount updatedAnnual report

    「Total research and development expenses amounted to ¥132 million in the current second-quarter cumulative period. By segment, research and development expenses amounted to ¥132 million in the Japan segment and ¥0 million in the United States segment.」

    Research and development expenses for the second-quarter cumulative period amounted to ¥132 million, comprising ¥132 million in the Japan segment and ¥0 million in the United States segment.
  17. FY2021-Q1Quarterly cumulative amount updatedAnnual report

    「Total research and development expenses amounted to ¥63 million in the current first-quarter cumulative period. By segment, research and development expenses amounted to ¥63 million in the Japan segment and ¥0 million in the United States segment.」

    Research and development expenses for the first-quarter cumulative period amounted to ¥63 million, comprising ¥63 million in the Japan segment and ¥0 million in the United States segment.
  18. FY2020-Q3Cumulative amount updatedAnnual report

    「Research and development activities amounted to ¥161 million in the current third-quarter cumulative period.」

    Research and development expenses of ¥161 million were disclosed for the third-quarter cumulative period.
  19. FY2020-Q2Cumulative amount updatedAnnual report

    「Research and development activities amounted to ¥111 million in the current second-quarter cumulative period.」

    Research and development expenses of ¥111 million were disclosed for the second-quarter cumulative period.
  20. FY2020-Q1Quarterly cumulative amount updatedAnnual report

    「Research and development expenses amounted to ¥53 million in the current first-quarter cumulative period.」

    Research and development expenses of ¥53 million were disclosed for the first-quarter cumulative period. There has been no material change in research and development activities.
  21. FY2019Full-year amount updatedAnnual report

    「Total research and development expenses incurred during the current consolidated fiscal year amounted to ¥198.977 million.」

    Total annual research and development expenses of ¥198.977 million were disclosed, down from ¥210.719 million in the previous year.
  22. FY2019-Q3Quarterly cumulative amount updatedAnnual report

    「Research and development activities amounted to ¥147 million in the current third-quarter cumulative period.」

    Research and development expenses of ¥147 million were disclosed for the third-quarter cumulative period.
  23. FY2019-Q2Cumulative amount updatedAnnual report

    「Research and development activities amounted to ¥95 million in the current second-quarter cumulative period.」

    Research and development expenses of ¥95 million were disclosed for the second-quarter cumulative period.
  24. FY2019-Q1Quarterly cumulative amount updatedAnnual report

    「Research and development activities amounted to ¥44 million in the current first-quarter cumulative period.」

    Research and development expenses of ¥44 million were disclosed for the first-quarter cumulative period.
  25. FY2018Full-year amount updatedAnnual report

    「Total research and development expenses incurred during the current consolidated fiscal year amounted to ¥210.719 million.」

    Total annual research and development expenses of ¥210.719 million were disclosed.
  26. FY2018-Q3Cumulative amount updatedAnnual report

    「Research and development activities amounted to ¥150 million in the current third-quarter cumulative period.」

    Research and development expenses of ¥150 million were disclosed for the third-quarter cumulative period.
  27. FY2018-Q2Cumulative amount updatedAnnual report

    「Research and development activities amounted to ¥93 million in the current second-quarter cumulative period.」

    Research and development expenses of ¥93 million were disclosed for the second-quarter cumulative period.
  28. FY2018-Q1Quarterly cumulative amount updatedAnnual report

    「Research and development activities amounted to ¥45 million in the current first-quarter cumulative period.」

    Research and development expenses of ¥45 million were disclosed for the first-quarter cumulative period.
  29. FY2017Full-year amount updatedAnnual report

    「Total research and development expenses incurred during the current consolidated fiscal year amounted to ¥172.939 million.」

    Total annual research and development expenses of ¥172.939 million were disclosed.
  30. FY2017-Q3Cumulative amount updatedAnnual report

    「Research and development activities amounted to ¥127 million in the current third-quarter cumulative period.」

    The disclosed research and development expenses for the third-quarter cumulative period amounted to ¥127 million.
  31. FY2017-Q2Cumulative amount updatedAnnual report

    「Research and development activities amounted to ¥84 million in the current second-quarter cumulative period.」

    The disclosed research and development expenses for the second-quarter cumulative period amounted to ¥84 million.
  32. FY2017-Q1First statedAnnual report

    「Research and development activities amounted to ¥43 million in the current first-quarter cumulative period.」

    Research and development expenses of ¥43 million were disclosed for the current first-quarter cumulative period.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Wakou Shokuhin's next results are scheduled for 2026-11-13. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.